ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.425,73
0,85%
S&P 500
5.998,74
-0,38%
Dow Jones
44.722,06
-0,31%
Euro vs US Dollar
1,05799
0,18%
Bitcoin
96.326,64
0,70%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Rogers Corp (ROG)

  7. Rogers Corp (ROG) News

ROG

Rogers (ROG)

Rogers Corp
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:ROG
DatumZeitQuelleÜberschriftSymbolFirma
18/11/202407h00PR Newswire (US)Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERENYSE:ROGRogers Corp
18/11/202407h00PR Newswire (US)Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERENYSE:ROGRogers Corp
12/11/202422h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ROGRogers Corp
12/11/202418h54Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:ROGRogers Corp
08/11/202422h16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ROGRogers Corp
08/11/202400h20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ROGRogers Corp
25/10/202419h51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ROGRogers Corp
24/10/202422h06Edgar (US Regulatory)Form 8-K - Current reportNYSE:ROGRogers Corp
24/10/202422h05Business WireRogers Corporation Reports Third Quarter 2024 ResultsNYSE:ROGRogers Corp
18/10/202420h13PR Newswire (US)Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOYNYSE:ROGRogers Corp
10/10/202422h05Business WireRogers Corporation Schedules Third Quarter 2024 Earnings Call for October 24NYSE:ROGRogers Corp
08/10/202407h00PR Newswire (US)Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general publicNYSE:ROGRogers Corp
08/10/202407h00PR Newswire (US)Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general publicNYSE:ROGRogers Corp
06/09/202418h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ROGRogers Corp
19/08/202421h28Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:ROGRogers Corp
15/08/202423h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ROGRogers Corp
15/08/202421h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ROGRogers Corp
13/08/202415h00GlobeNewswire Inc.Ram Mayampurath to Join MKS Instruments as Chief Financial OfficerNYSE:ROGRogers Corp
12/08/202422h05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ROGRogers Corp
12/08/202422h05Business WireRogers Corporation Announces Departure of Chief Financial OfficerNYSE:ROGRogers Corp
01/08/202418h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ROGRogers Corp
31/07/202422h13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ROGRogers Corp
30/07/202417h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ROGRogers Corp
29/07/202422h05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ROGRogers Corp
25/07/202422h05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ROGRogers Corp
25/07/202422h05Business WireRogers Corporation Reports Second Quarter 2024 ResultsNYSE:ROGRogers Corp
25/07/202415h00PR Newswire (US)Roche showcases solutions for laboratories of the future at the Association for Diagnostics & Laboratory Medicine 2024 Clinical Lab ExpoNYSE:ROGRogers Corp
19/07/202420h04Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:ROGRogers Corp
11/07/202422h05Business WireRogers Corporation Schedules Second Quarter 2024 Earnings Call for July 25NYSE:ROGRogers Corp
01/07/202422h30Business WireRogers Corporation Releases Its 2024 Environmental, Social and Governance ReportNYSE:ROGRogers Corp
 Showing the most relevant articles for your search:NYSE:ROG

Kürzlich von Ihnen besucht

BIT
SDAX5L
SG Issuer Societe Generale
BIT
S29773
Societe Generale Effekten
BIT
CSUK
Exchange Traded
BIT
IRCP
Exchange Traded
BIT
MTVFR
Mondo TV France
BIT
F29599
Vontobel Financial Produ...
BIT
SEXO5S
Societe Generale Effekten
BIT
UC8MSN
Unicredit Bank
BIT
PEMD
Invesco Emerging Markets...
BIT
F37635
Vontobel Financial Produ...
BIT
F37657
Vontobel Financial Produ...
BIT
P1HCR6
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten

BLACK FRIDAY

ADVFN

Seit 25 Jahren im Geschäft 1999-2024

Sparen Sie bis zu 60%* für Euronext Level 2

1 Jahr 40%, 2 Jahre 50% und *3 Jahre 60%

*Über 3 Jahre 1094.04€, jetzt nur noch 437.62€